Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Baclofen in cluster headache.

R Hering-Hanit1, N Gadoth

  • 1Department of Neurology, Meir General Hospital, Kfar Saba, and the Sackler Faculty of Medicine, Tel Aviv University, Israel.

Headache
|April 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polysomnographic characteristics of severe obstructive sleep apnea vary significantly between hypertensive and normotensive patients of both genders.

Sleep & breathing = Schlaf & Atmung·2020
Same author

Pitfalls in the diagnosis of epilepsy during adolescence.

International journal of adolescent medicine and health·2012
Same author

Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.

European journal of cancer care·2009
Same author

Fragile X associated tremor/ataxia syndrome (FXTAS) with dementia in a female harbouring FMR1 premutation.

Journal of neurology, neurosurgery, and psychiatry·2008
Same author

Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies.

Neurology·2007
Same author

Case report: multiple endocrine neoplasia type 2B misdiagnosed as familial dysautonomia.

European journal of paediatric dentistry·2005
Same journal

Hypothalamus as a conductor of the migraine prodrome: A narrative review.

Headache·2026
Same journal

New academic year in Headache.

Headache·2026
Same journal

Essential readings in headache medicine: Top 10 educational articles from 2025.

Headache·2026
Same journal

Pain reduction and tolerability of mirogabalin in trigeminal neuralgia: A prospective observational study.

Headache·2026
Same journal

Risk of hypertension after CGRP antagonist treatment in migraine: A systematic review and meta-analysis.

Headache·2026
Same journal

Nummular headache responsive to suzetrigine, a novel, selective sodium channel antagonist.

Headache·2026
See all related articles

Baclofen, an antispastic drug, shows promise in preventing severe cluster headache attacks. This pilot study found that baclofen effectively reduced or eliminated attacks in most patients, offering a new potential treatment for this rare neurological disorder.

Area of Science:

  • Neurology
  • Neuroscience
  • Pharmacology

Background:

  • Cluster headache is a rare, severe neurological disorder characterized by unilateral, short-lived attacks with autonomic symptoms.
  • Existing prophylactic treatments for cluster headache are numerous but often difficult to manage or have limited efficacy.
  • Baclofen, an antispastic agent with known antinociceptive properties, has demonstrated efficacy in other pain conditions.

Purpose of the Study:

  • To investigate the potential efficacy of baclofen as a prophylactic treatment for cluster headache.
  • To assess the tolerability and effectiveness of baclofen in reducing the frequency and severity of cluster headache attacks.

Main Methods:

  • A pilot study involving nine patients diagnosed with cluster headache.
  • Patients were administered baclofen at doses ranging from 15 to 30 mg daily, divided into three doses.

Related Experiment Videos

  • Treatment response was monitored for attack cessation and overall improvement.

    • Main Results:

    • Six out of nine patients reported complete cessation of cluster headache attacks within one week of starting baclofen.
    • A seventh patient experienced substantial improvement and became attack-free by the second week.
    • Two patients experienced a worsening of attacks and required corticosteroid treatment.

    Conclusions:

    • Baclofen appears to be an effective and well-tolerated option for the prevention of cluster headache attacks in a majority of patients.
    • This pilot study suggests baclofen may represent a novel therapeutic strategy for managing cluster headache.
    • Further research is warranted to confirm these findings in larger, controlled trials.